Navigation Links
Pharmasset Reports Fiscal First Quarter 2011 Financial Results
Date:2/7/2011

PRINCETON, N.J., Feb. 7, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended December 31, 2010.

Financial ResultsRevenues were $0.2 million during the quarter ended December 31, 2010 compared to $0.3 million for the quarter ended December 31, 2009 and include amortization of up-front and subsequent collaborative and license payments received from Roche.

Net cash used in operating activities during the three months ended December 31, 2010 was $24.0 million. Pharmasset held $102.7 million in cash and cash equivalents as of December 31, 2010. On January 26, 2011, we completed a common stock offering raising an additional $123.4 million.

Total operating expenses for the quarter ended December 31, 2010 were $23.8 million as compared to $13.4 million for the same period in 2009. The increase in operating expenses for the quarter ended December 31, 2010 was primarily the result of preclinical and clinical trial costs for PSI-7977 and PSI-938 of which $5.9 million was related to API manufacturing (and related drug supply) costs and pegylated interferon and ribavirin costs for the studies of PSI-7977 and PSI-938.

Pharmasset reported a net loss of $23.5 million, or $0.69 per share, for the quarter ended December 31, 2010, as compared to a net loss of $13.9 million, or $0.49 per share, for the quarter ended December 31, 2009.

Recent Operational Highlights:-- Presented final Phase 2a results with PSI-7977 at the American Association for the Study of Liver Diseases (AASLD) in October 2010

-- Initiated Part 2 of a Phase 1 study that includes combinations of PSI-7977 and PSI-938

-- Roche reported 12 week interim results f
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 , La ... contribuye a adquirir tolerancia a la proteína de ... proteína de la leche de la vaca (APLV) es la ... Hasta ahora, la APLV se trataba eliminando las ... demostrado que es posible adquirir tolerancia oral en ...
(Date:10/30/2014)... Pharmaceuticals, Inc. today announced that it has received final ... (FDA) on its Abbreviated New Drug Application (ANDA) for ... to Eisai Inc.,s Aricept® 23mg.  Aricept® 23mg is used ... is preparing to launch the product in the US ... USA , at the earliest time possible. ...
(Date:10/30/2014)... , Oct. 29, 2014 Electrodes ... potential which can be amplified to diagnose as ... electrodes used in medical devices facilitate the detection ... from muscle cells and neurons of the patients. ... utilize the radiofrequency alternating current to perform minimally ...
Breaking Medicine Technology:Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, EEG, EMG, ERG and Fetal Scalp Electrodes, Therapeutic Electrodes - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - Global Industry Analysis, Size, Share, G 2Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, EEG, EMG, ERG and Fetal Scalp Electrodes, Therapeutic Electrodes - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - Global Industry Analysis, Size, Share, G 3Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, EEG, EMG, ERG and Fetal Scalp Electrodes, Therapeutic Electrodes - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - Global Industry Analysis, Size, Share, G 4
... , , , ... Failure Society of America,s (HFSA) 13th Annual Scientific Meeting ... This three-day meeting -- a forum for heart failure specialists to present ... research and new developments in the approach to treating patients with this ...
... ORLANDO, Florida, September 14 , ... System Will Help Novant,Hospitals Ensure Patient Safety and Quality, ... Inc., an Elsevier company and leading provider of advanced,solutions ... Novant Health, a not-for-profit integrated group of,hospitals and physician ...
Cached Medicine Technology:Heart Failure Society of America 13th Annual Scientific Meeting to Focus on a Bench-To-Bedside Approach 2Heart Failure Society of America 13th Annual Scientific Meeting to Focus on a Bench-To-Bedside Approach 3Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 2Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 3Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 4
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, 2014 ... of three West African nations ravaged by the disease -- ... Dr. Bruce Aylward, WHO,s assistant director general, said there,s been ... no increase in laboratory-confirmed cases. He said he was cautiously ... be making some progress, The New York Times ...
(Date:10/30/2014)... October 30, 2014 USARAD ... Accredited teleradiology and specialty telemedicine solutions provider, including ... to its existing teleradiology services at Mission Bend ... and expert telemedicine services, to the state-of-the-art, 24/7, ... a result of this innovative partnership, there will ...
(Date:10/30/2014)... Sound Telecom, a leader in the call center ... any time they wonder, “Should I use an answering service?” ... them through a series of yes or no questions that ... There are many considerations and scenarios that come into play ... service . This decision infographic serves as a bit of ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- Many U.S. colleges ... even though tanning increases the risk for skin ... young adults, particularly white women, so colleges should ... the researchers said. "Public health efforts are ... awareness of the harms that indoor tanning poses ...
(Date:10/30/2014)... new standard of care for children facing acute myeloid ... published in the latest edition of the New ... by John Wagner, Jr., M.D., director of the Pediatric ... Minnesota and a researcher in the Masonic Cancer Center, ... leukemia and myelodysplastic syndrome who received transplants of either ...
Breaking Medicine News(10 mins):Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 3
... HealthDay Reporter , MONDAY, March 28 (HealthDay News) -- ... the brain that,s similar to when people suffer physical ... serious rejection can be sometimes," said study author Edward ... "When people are saying ,I really feel in pain ...
... your chances of losing weight, reduce your stress level and get ... to lose at least 10 pounds were more likely to reach ... than six hours but not more than eight hours a night. ... Obesity , was the result of a study funded by the ...
... recent decision was made to merge the National Institute ... Institute on Drug Abuse (NIDA) into a yet unnamed ... who co-authored the paper) believe that since alcohol is ... merging the two institutes could significantly hinder the scientific ...
... CHICAGOMultiple Sclerosis (MS) is an unpredictable, often debilitating ... affects more than 400,000 Americans. Patients with MS ... and psychological impacts of their condition. Northwestern Medicine,s ... care and is the first in the Midwest ...
... Serena Gordon HealthDay Reporter , MONDAY, March 28 ... and Twitter, have become nearly inescapable facets of modern life, ... can have real benefits and risks for children. These ... each other and they are where children and adolescents are ...
... HealthDay Reporter , MONDAY, March 28 (HealthDay News) ... screen U.S. airline passengers is not a significant health ... have arisen since the U.S. Transportation Safety Administration (TSA) ... now operates 486 scanners in 78 U.S. airports, and ...
Cached Medicine News:Health News:Romantic Rejection May Hurt Just Like Physical Pain 2Health News:Moderate sleep and less stress may help with weight loss 2Health News:Moderate sleep and less stress may help with weight loss 3Health News:Commentary: When creating a new institute, the devil's in the details 2Health News:Commentary: When creating a new institute, the devil's in the details 3Health News:Northwestern Medicine multiple sclerosis program earns national designation 2Health News:Northwestern Medicine multiple sclerosis program earns national designation 3Health News:Social Media Has Good and Bad Effects on Kids: Experts 2Health News:Social Media Has Good and Bad Effects on Kids: Experts 3Health News:Airport Scanners Appear Safe, Study Finds 2Health News:Airport Scanners Appear Safe, Study Finds 3Health News:Airport Scanners Appear Safe, Study Finds 4
Inquire...
... Multifocal IOL was designed to provide a ... glasses in most situations. While distance vision ... to that of a single vision monofocal ... and about 19 in 20 people with ...
The Pach IV is the premier product for cornea thickness measurement in conjunction with Glaucoma screening....
... Zeus Scientific, Inc. Measles test ... qualitative and quantitative detection of ... by the indirect fluorescent antibody ... determine or confirm recent infection ...
Medicine Products: